title: Heparins in the new millennium: will unfractionated heparin survive? Introduction.
authors.affiliation: Department of Pathology, Loyola University Medical Center, Chicago, Illinois, USA.
authors.forename: K D
authors.initials: KD
authors.lastname: McClatchey
authors.forename: H M
authors.initials: HM
authors.lastname: Galvin
authors.forename: R M
authors.initials: RM
authors.lastname: Galvin
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology; D014652:Vascular Diseases / Q000188:drug therapy / Q000209:etiology
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin